Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
about
Epigenetics of colorectal cancerReview of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsThe immunogenicity of colorectal cancers with high-degree microsatellite instabilitySerrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapyPharmacologic resistance in colorectal cancer: a reviewLynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancerTumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes?EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer ProgressionMolecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future PerspectiveGenetics and Genetic Biomarkers in Sporadic Colorectal CancerMicrosatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastasesCarcinogenesis and microsatellite instability: the interrelationship between genetics and epigeneticsViolacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cellsRelationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancersFrameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expressionDefective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.Utility of p16 immunohistochemistry for the identification of Lynch syndromeSpecific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in ItalyThe biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedsideMicrosatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in IsraelModel-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.Genomic and epigenetic instability in colorectal cancer pathogenesis.Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto RicoGenotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford RobertsMicrosatellite instability and survival in rectal cancer.5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity.Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinClinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics?A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.Evidence for an hMSH3 defect in familial hamartomatous polyps.Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer
P2860
Q24598045-2FC5A423-223C-475D-AD07-D9180CD351EEQ24610838-EF03752C-BC9A-4070-B47E-6D6D0D984AC7Q24814928-3F782815-D6CB-4652-8184-9EF4F637EAF8Q26751035-28321C72-3C6C-4DA9-AC0D-455D256A0C06Q26769850-83BC8091-39EE-4FD0-A1E0-140898880100Q26797255-B42FE34C-A540-459D-B8D9-716E3B1F21A3Q26864622-9B982FD3-A6AF-4425-908D-F189106D513EQ26995653-3179061A-0AEB-4DC4-9844-6E4A2B1265A0Q28070038-79B42B99-5E12-4166-93DE-CE492C653D58Q28084346-A7062DE4-AE1C-4B97-83E3-5CDEC110E77FQ28247135-DC2EE9DD-5797-45BE-8A81-1CE47FA879E6Q28253670-4B55BDA4-2206-4742-A764-8E8C25D2B678Q28286398-1BDC343A-AF7F-4CDA-9C1E-1A7E7C1122E3Q33213711-9D3367FD-BCEC-4A97-A4D8-2BDDB0D1595AQ33383621-2D2C021D-48FA-4C30-B8C6-031AE742EB61Q33401080-AF79627B-1336-4AE2-80C3-2B7FF34F6F6DQ33586020-A34BBC07-DBFF-4CC6-AA0C-0FA05A9D1CFAQ33632100-F0889A57-7F5A-4000-8C52-4456DB7F2147Q33675252-C45E7541-DFC8-4D19-9ACF-124AB1C8DC96Q33725467-6D80537C-611C-4174-87BC-13B3F09B1CC2Q33756141-68F8E6AE-DEFB-4FA8-B089-9F61679EC8C1Q33762979-6867E89F-E356-4D8C-9387-9E5757902021Q33791731-C26C3F2A-CDFC-45C1-8789-66CCD6F58F8FQ33792250-E978263E-1497-46DC-8324-B4487BF38682Q33793501-1278D19A-1E45-42C1-B050-C3121BEE4E30Q33836026-ABC5E117-F638-4860-8C83-92E937D7BBF1Q33862772-8CFEE83C-C57C-4B36-9403-BE72C51E5F35Q33939068-1B4627CE-84F9-4E6E-B6EC-E7DED2970925Q33945019-30EF2977-CFDC-49F3-B4EF-B2E5F55678F5Q33954707-ABD37E75-DE22-4611-91D7-7F66140E1358Q34059750-F8967568-E962-4BC5-94A3-9038B83C48EFQ34099011-18D95241-7F55-4B3C-8851-3810CC46871DQ34131764-EAD65F60-B7B9-48D8-B843-2D077DCEF348Q34138105-D754B882-F806-4CE7-9CE6-BA4FAD5ACA20Q34138113-0D3A357F-7F57-4DA4-AB72-2083157216D1Q34158885-39007E54-6AE3-404D-99AC-74232B4A944DQ34293192-45EC4320-482F-49E6-9C49-0E95BD030814Q34408875-1AAC8256-5749-4F17-B0D7-64E7434ABD34Q34420082-9129CD50-B3E2-4E1B-B472-FA89AF50CDAFQ34472453-242AFC83-88EB-429A-BF37-DA79C051CC6E
P2860
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.
@en
type
label
Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.
@en
prefLabel
Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.
@en
P2093
P1433
P1476
Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.
@en
P2093
Akihiro Tajima
Betty L Cabrera
C Richard Boland
Christian A Arnold
Cynthia A Behling
E Julieta Smith
John M Carethers
Katsumi Miyai
Lanchinh Nguyen
P304
P356
10.1053/J.GASTRO.2003.12.023
P407
P577
2004-02-01T00:00:00Z